James A. Heslop - Concepedia

Author

James A. Heslop

Medical University of South Carolina ORCID

Also Known As

Davenport, Anthony P., Heslop, James, J. Heslop, James A. Heslop, James Heslop, T R

Publications

911

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina University of Liverpool University of Oxford AstraZeneca (United Kingdom)Newcastle University

About

James A. Heslop is an author at Medical University of South Carolina specializing in cell biology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	268
2	Natural Sciences	3	3	214
3	Business	1	1	21
4	Health Sciences	1	1	38
5	Law	1	1	21

James A. Heslop

Publications

595

Citations

H-Index

Page 1

	Year	Citations
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 Teresa Brevini, Mailis Maes, Gwilym J. Webb, Nature	2022	282
Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile James A. Heslop, Cliff Rowe, Joanne Walsh, Archives of Toxicology Drug DispositionKey FactorsSelective Dedifferentiation ProfileMechanistic EvaluationProteomic Technology	2016	135
GATA6 defines endoderm fate by controlling chromatin accessibility during differentiation of human-induced pluripotent stem cells James A. Heslop, Behshad Pournasr, Jui-Tung Liu, Cell Reports GeneticsChromatin AccessibilityEpigeneticsTranscriptional RegulationGata Family	2021	69
MicroRNA-122: A Novel Hepatocyte-Enriched in vitro Marker of Drug-Induced Cellular Toxicity Richard Kia, Lorna Kelly, Rowena Sison‐Young, Toxicological Sciences Cell Culture MediaImmunologyCell DeathPathologyHepatotoxicity	2014	38
Implications of Applying a Private Sector Based Reporting Model to Not‐for‐Profit Entities: The Treatment of Charitable Distributions by Charities in New Zealand Chris van Staden, James A. Heslop Australian Accounting Review Corporate TaxLawPublic-private PartnershipSocial AccountingAuditing	2009	21
PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression Daniel Corum, Dorea P. Jenkins, James A. Heslop, Journal of Biological Chemistry Endothelial CellsMitochondrial DysfunctionApoptosisMitochondrial BiologyOxidative Stress	2020	16
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B Jui-Tung Liu, Caren Doueiry, Yulin Jiang, Communications Biology	2023	13
Enhanced genome editing in human iPSCs with CRISPR-CAS9 by co-targeting <i>ATP1a1</i> Jui-Tung Liu, James Corbett, James A. Heslop, PeerJ	2020	11
Chromatin remodeling is restricted by transient GATA6 binding during iPSC differentiation to definitive endoderm James A. Heslop, Behshad Pournasr, Stephen A. Duncan iScience GeneticsEpigeneticsDefinitive Endoderm CommitmentTranscriptional RegulationIpsc Differentiation	2022	10

Page 1